232
Participants
Start Date
November 1, 2011
Primary Completion Date
August 23, 2013
Study Completion Date
June 10, 2015
Ofatumumab 3mg
3mg of investigational product
Ofatumumab 30mg
30mg of investigational product
Ofatumumab 60mg
60mg of investigational product
Placebo
Placebo
GSK Investigational Site, Sofia
GSK Investigational Site, Sofia
GSK Investigational Site, Sofia
GSK Investigational Site, Sofia
GSK Investigational Site, Koebenhavn Ø
GSK Investigational Site, Hamar
GSK Investigational Site, Berlin
GSK Investigational Site, Castellon
GSK Investigational Site, Berlin
GSK Investigational Site, Córdoba
GSK Investigational Site, Girona
GSK Investigational Site, Philadelphia
GSK Investigational Site, Hamburg
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Achim
GSK Investigational Site, Málaga
GSK Investigational Site, Atlanta
GSK Investigational Site, Hanover
GSK Investigational Site, Miami
GSK Investigational Site, Sunrise
GSK Investigational Site, West Palm Beach
GSK Investigational Site, Tampa
GSK Investigational Site, Cullman
GSK Investigational Site, Verona
GSK Investigational Site, Nashville
GSK Investigational Site, Seville
GSK Investigational Site, Modena
GSK Investigational Site, Bochum
GSK Investigational Site, Fort Wayne
GSK Investigational Site, Baracaldo/Vizcaya
GSK Investigational Site, Grand Rapids
GSK Investigational Site, Cologne
GSK Investigational Site, Northbrook
GSK Investigational Site, Alzenau in Unterfranken
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Round Rock
GSK Investigational Site, Fullerton
GSK Investigational Site, Seattle
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Moscow
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Saint Petersburg
GSK Investigational Site, Smolensk
GSK Investigational Site, Kazan'
GSK Investigational Site, Nizhny Novgorod
GSK Investigational Site, Fairfield
GSK Investigational Site, Edmonton
GSK Investigational Site, Montreal
GSK Investigational Site, Brno
GSK Investigational Site, Brno
GSK Investigational Site, Jihlava
GSK Investigational Site, Olomouc
GSK Investigational Site, Teplice
GSK Investigational Site, Leipzig
GSK Investigational Site, Sittard-geleen
GSK Investigational Site, Venray
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
Lead Sponsor
GlaxoSmithKline
INDUSTRY